Product Information

PREGABALIN 225 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.0683 per EA under NDC 13668036405. Its NADAC has been published 48 times since Dec 17, 2025.

FDA first approved this application on Feb 21, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 225 MG CAPSULE

Pregabalin
$0.0683per EA
DEA Schedule CV

Strength

225 mg/1

NDC

13668036405

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA206942

FDA Approved

2/21/2025

TE Code

AB

On Market Since

5/19/2025

Price Statistics

The NADAC for PREGABALIN 225 MG CAPSULE has been published 48 times since Dec 17, 2025, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0683 per EA
All-time high$0.0683 (Nov 11, 2026)
All-time low$0.0543 (Jul 22, 2026)
52-week high$0.0683
52-week low$0.0543
Median price$0.0586
Average price$0.0594
Largest weekly change+13.0% (Sep 23, 2026)
Weeks tracked48
Tracking sinceDec 17, 2025

Price History

1W

0.0%

1M

+7.6%

3M

+25.7%

6M

+21.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

+8.4%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 225 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $0.0683 per EA (NDC 13668036405), effective Nov 11, 2026.

How has the price of PREGABALIN 225 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has risen 8.4%. It has been tracked across 48 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?

Since Dec 17, 2025, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0543 (Jul 22, 2026) to a high of $0.0683 (Nov 11, 2026), with a median of $0.0586 per EA.

Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 225 MG CAPSULE, is $0.0609 per EA — about 11% below PREGABALIN 225 MG CAPSULE.

Who manufactures PREGABALIN 225 MG CAPSULE?

PREGABALIN 225 MG CAPSULE (NDC 13668036405) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.